Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Anavex Lf SC (AVXL)

Anavex Lf SC (AVXL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Anavex Lf SC 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 USA

www.anavex.com Employees: 34 P: 844-689-3939

Sector:

Medical

Description:

ANAVEX LIFE SCIENCES CORP. is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company's proprietary SIGMACEPTOR Discovery Platform involves the rational drug design of compounds that fulfill specific criteria based on unmet market needs and new scientific advances. Selected drug candidates demonstrate high, non-exclusive affinity for sigma receptors, which are involved in the modulation of multiple cellular biochemical signaling pathways.

Key Statistics

Overview:

Market Capitalization, $K 473,544
Enterprise Value, $K 370,964
Shares Outstanding, K 89,348
Float, K 79,162
% Float 88.60%
Short Interest, K 19,651
Short Float 21.99%
Days to Cover 8.01
Short Volume Ratio 0.65
% of Insider Shareholders 11.40%
% of Institutional Shareholders 31.55%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -46,380 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,830 K
EBIT, $ -51,400 K
EBITDA, $ -51,400 K

Growth:

1-Year Return -46.95%
3-Year Return -49.81%
5-Year Return -15.61%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -20.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.11 on 11/25/25
Next Earnings Date 02/11/26 [--]
Earnings Per Share ttm -0.54
EPS Growth vs. Prev Qtr 31.25%
EPS Growth vs. Prev Year 21.43%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 10/07/15

AVXL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -46.78%
Return-on-Assets % -41.46%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.55
Book Value/Share 1.10
Interest Coverage -2.36
60-Month Beta 1.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar